Figure 6
From: Tocilizumab degradation via photo-catalytic ozonation process from aqueous

(a) Ultraviolet–Visible spectroscopy and, (b–d) Diffuse Reflectance Spectroscopy analysis of BiOI, MOF, and BiOI-MOF.
From: Tocilizumab degradation via photo-catalytic ozonation process from aqueous

(a) Ultraviolet–Visible spectroscopy and, (b–d) Diffuse Reflectance Spectroscopy analysis of BiOI, MOF, and BiOI-MOF.